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ABSTRACT
Objectives: According to National Health Service
England (NHSE) specialist respiratory commissioning
specification for complex home ventilation, patients
with weaning failure should be referred to a specialist
centre. However, there are limited data reporting the
clinical outcomes from such centres.
Setting: Prospective observational cohort study of
patients admitted to a UK specialist weaning,
rehabilitation and home mechanical ventilation centre
between February 2005 and July 2013.
Participants: 262 patients admitted with a median
age of 64.2 years (IQR 52.6–73.2 years). 59.9% were
male.
Results: 39.7% of patients had neuromuscular and/or
chest wall disease, 21% were postsurgical, 19.5% had
chronic obstructive pulmonary disease (COPD), 5.3%
had obesity-related respiratory failure and 14.5% had
other diagnoses. 64.1% of patients were successfully
weaned, with 38.2% weaned fully from ventilation,
24% weaned to nocturnal non-invasive ventilation
(NIV), 1.9% weaned to nocturnal NIV with intermittent
NIV during the daytime. 21.4% of patients were
discharged on long-term tracheostomy ventilation.
The obesity-related respiratory failure group were most
likely to wean (relative risk (RR) for weaning
success=1.48, 95% CI 1.35 to 1.77; p<0.001), but
otherwise weaning success rates did not significantly
vary by diagnostic group. The median time-to-wean
was 19 days (IQR 9–33) and the median duration of
stay was 31 days (IQR 16–50), with no difference
observed between the groups. Weaning centre
mortality was 14.5%, highest in the COPD group
(RR=2.15, 95% CI 1.19 to 3.91, p=0.012) and
lowest in the neuromuscular and/or chest wall
disease group (RR=0.34, 95% CI 0.16 to 0.75,
p=0.007). Of all patients discharged alive, survival
was 71.7% at 6 months and 61.8% at 12 months
postdischarge.
Conclusions: Following NHSE guidance, patients with
weaning delay and failure should be considered for
transfer to a specialist centre where available, which
can demonstrate favourable short-term and long-term
clinical outcomes.
INTRODUCTION
The majority of patients admitted to the
intensive care unit (ICU) requiring invasive
mechanical ventilation can be weaned
promptly on resolution and reversal of the
primary insult. However, 31% of patients fail
their initial spontaneous breathing trial
(SBT) and require up to three SBTs, or up
to 7 days from the ﬁrst SBT, to achieve
successful weaning with 7% of patients
remaining ventilated longer than 1 week.1
Although there are emerging strategies to
identify such patients at an early stage of
critical illness,2 these patients with weaning
failure who require prolonged mechanical
ventilation have a greater ICU mortality,
even after adjustment of confounding vari-
ables.3 4 Increasingly, specialist weaning,
rehabilitation and home ventilation centres
Strengths and limitations of this study
▪ This study reports the clinical outcomes of a
large cohort of patients with weaning failure
admitted to a specialist weaning and rehabilita-
tion centre.
▪ Details of clinical outcomes including
time-to-wean, weaning success, weaning centre
mortality and 1 year survival based on primary
diagnostic case mix were included.
▪ The data describing the total duration of invasive
ventilation are incomplete; however, all patients
included met internationally accepted criteria for
definition of weaning failure prior to admission.
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are emerging to treat these patients, and the number
of patients transferred to such units has been steadily
growing in the USA3 and Europe,4 with variable out-
comes reported.5–16
We report the outcome data of a national specialist
weaning, rehabilitation and home mechanical ventila-
tion unit in a London university teaching hospital,
which since 1995 has taken referrals from ICUs across
England and Wales. We have previously reported on
costs and survival,13 but with National Health Service
England (NHSE) specialist commissioning of complex
home ventilation services,17 it is now essential for all
such units to collect, analyse and publish their data, so
that referral patterns, patient case mix and clinical
outcome data can be benchmarked both nationally and
internationally.
METHODS
Defined clinical cohort
Data were prospectively collected from patients admit-
ted to a UK specialist weaning, rehabilitation and home
mechanical ventilation centre between February 2005
and July 2013. The study was conceived as a service
evaluation and therefore assessment by the local
research ethics committee was not required, but all
data were anonymised. Patients were excluded if (1)
they were receiving invasive tracheostomy ventilation,
but were admitted for stabilisation and enhancement of
the community care package to facilitate discharge to
home or nursing home rather than admission for an
attempt at weaning (eg, high spinal cord injury, cata-
strophic brain injury) or (2) they had been successfully
weaned from invasive tracheostomy ventilation at the
referring ICU and transferred for rehabilitation and
establishment of home non-invasive ventilation (NIV).
Weaning failure was deﬁned as a patient transferred for
weaning but deemed unsuitable following completion
of a comprehensive multidisciplinary assessment in the
weaning centre and all further weaning attempts dis-
continued. In essence, this was deﬁned as patients
requiring invasive ventilation at discharge or a time of
death if they died in the centre. Weaning success was
deﬁned as a patient being liberated from invasive
respiratory support at the time of discharge from the
weaning centre.
Data collection tool
Data were prospectively collected from a bespoke elec-
tronic medical records and chart system, including all
clinical notes and medical discharge summaries (ICIP
Carevue, Philips, Eindhoven, The Netherlands), from
referral letters and the hospital electronic patient
records system. Data were also collected from the refer-
ring hospital and the general practitioner by telephone
and letter. The primary data record included age on
admission, gender, primary diagnostic category, referring
hospital, date of admission, date weaned from invasive
mechanical ventilation, date of discharge, weaning
outcome, discharge destination and date of death (if
applicable). The secondary data record included
time-to-wean (calculated as days between admission to
the weaning and rehabilitation centre and removal of
tracheostomy), length-of-stay (days between admission to
and discharge from the weaning and rehabilitation
centre) and postcentre discharge survival rate (propor-
tion of patients alive from date of discharge from the
weaning and rehabilitation centre up to 12 months
postdischarge).
Primary diagnostic groups
The primary diagnosis implicated in causing chronic
respiratory failure and prolonged mechanical ventilation
were classiﬁed into ﬁve diagnostic groups based on aeti-
ology including (1) neuromuscular disorders and chest
wall disease; (2) chronic obstructive pulmonary disease
(COPD); (3) postsurgical; (4) obesity-related respiratory
failure (ORRF), including obstructive sleep apnoea
and/or obesity hypoventilation syndrome; and (5) other
causes of chronic respiratory failure. The primary diag-
nosis was established at the weekly multidisciplinary
meeting.
Clinical outcome set
All patients received a bespoke weaning plan with twice
daily medical reviews with the plan developed at the
once weekly multidisciplinary weaning team meeting.
We use a speciﬁc, non-protocolised approach to these
complex weaning patients.18 The core clinical outcome
set included rates of weaning success and weaning
centre mortality, time-to-wean, and survival rate in the
ﬁrst 12 months after hospital discharge. Weaning out-
comes were further classiﬁed into the following categor-
ies (1) self-ventilating day and night; (2) weaned onto
nocturnal NIV; (3) weaned onto nocturnal NIV with
intermittent daytime NIV use; (4) tracheostomy ventila-
tion dependent (weaning failure); and (5) death within
the weaning and rehabilitation centre which included
patients weaned from invasive ventilation, but died prior
to discharge from hospital.
Statistical analysis
Data were analysed using the Statistical Program for the
Social Sciences (SPSS) V.22 (SPSS Inc, Chicago, Illinois,
USA). Non-parametric data were expressed as median
and IQR and compared using the Mann-Whitney U test
or the Kruskal-Wallis test. Proportions were compared
using the χ2 test for association or trend or Fisher’s
exact test as appropriate. Relative risk (RR) ratios were
calculated using MedCalc (MedCalc.org, Ostend,
Belgium) and we have reported the likelihood of suc-
cessful weaning and death. Kaplan-Meier analysis was
used to assess survival, with the log-rank test used to
compare between groups. Statistical signiﬁcance was
accepted as a p value <0.05.
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RESULTS
Demographics
During the study period, 262 patients were admitted.
The median age was 64.2 years (IQR=52.6–73.2). In
total, 59.9% of patients were male (n=157), and 40.1%
were female (n=105). In total, 72.5% of patients (n=190)
were admitted as tertiary referrals from other hospitals,
and 27.5% (n=72) were referred internally from the hos-
pital ICU.
Primary diagnostic groups
Neuromuscular and chest wall disease were the largest
primary diagnostic category (n=105, 39.7%). The second
largest diagnostic group was postsurgical (n=55, 21.0%).
The third largest group was COPD (n=51, 19.5%) fol-
lowed by the other group (n=38, 14.5%), and the ORFF
group were the fewest in number (n=14, 5.3%). These
data, detailing the primary diagnoses recorded at admis-
sion to our unit within patients from each primary diag-
nostic group, are shown in table 1.
Weaning outcome by diagnostic group
Weaning success was observed in 64.1% of patients
(n=168). The most common outcome was successful
weaning to self-ventilation (n=100, 38.2%), followed by
weaning to nocturnal NIV only (n=63, 24.0%). A small
number of patients (n=5, 1.9%) were discharged requir-
ing NIV both nocturnally and intermittently during the
day. In total, 21.4% of patients (n=56) were discharged
on permanent tracheostomy ventilation. The weaning
outcomes are shown in ﬁgure 1 and table 2.
There was no signiﬁcant difference in weaning success
rates observed between patients in the neuromuscular-
chest wall disease (p=0.659), COPD (p=0.922) or postsur-
gical (p=0.571) diagnostic groups. The other diagnostic
group demonstrated the lowest successful weaning rate at
52.6% (n=20), though this was also not signiﬁcant.
Conversely, 92.9% of patients with a primary diagnosis of
ORRF were weaned successfully (RR for successful
weaning=1.48, 95% CI 1.35 to 1.77, p<0.001; table 3).
The likelihood of weaning success, by primary diag-
nostic group, is shown in table 3.
Mortality by diagnostic group
Overall, weaning centre mortality was 14.5% (n=38).
There was a difference in mortality between the diagnos-
tic categories with patients with COPD demonstrating an
increased weaning centre mortality (RR for death=2.15,
95% CI 1.19 to 3.91, p=0.012). Conversely, the
neuromuscular-chest wall disease group had a weaning
centre mortality of only 6.7% (RR for death=0.34, 95% CI
0.16 to 075, p=0.007), despite having a comparable rate
of weaning success. This was reﬂected in the fact that the
patients with neuromuscular/chest wall disease were
more frequently discharged on long-term tracheostomy
ventilation (n=32, 30.8%; p=0.004). The obese patients
with ORRF had a comparably low mortality with the
neuromuscular and chest wall disease group (table 4).
Time-to-wean
The median time-to-wean was 19 days (IQR=9–33 days;
range 0–121 days). There was no difference observed
between the diagnostic groups (p=0.478). As expected,
Table 1 Admission demographic and diagnosis of 262
patients admitted to a specialist weaning and rehabilitation
centre
Factor
Median (IQR)
or n (%)
Age 64.2 (52.6–73.6)
Male gender 157 (59.9%)
Tertiary admission 190 (72.5%)
Neuromuscular/chest wall disease 105 (39.7%)
Motor neuron disease 17 (6.5%)
Structural chest wall disease 16 (6.1%)
Guillain-Barré syndrome 13 (5.0%)
Muscular dystrophy 13 (5.0%)
Myotonic dystrophy 11 (4.2%)
Spinal cord injury 6 (2.3%)
Isolated postcritical care
neuromyopathy*
5 (1.9%)
Previous poliomyelitis 3 (1.1%)
Myasthenic syndrome 3 (1.1%)
Postsurgery 55 (21.0%)
Cardiothoracic 29 (11.1%)
Upper gastrointestinal 7 (2.7%)
Vascular surgery 6 (2.3%)
ENT/maxillofacial 5 (1.9%)
Lower gastrointestinal 4 (1.5%)
COPD 51 (19.5%)
Obesity-related respiratory failure 14 (5.3%)
Other diagnosis 38 (14.5%)
Interstitial lung disease 10 (3.8%)
Chronic respiratory infection 7 (2.7%)
Stroke 5 (1.9%)
Malignant disease 3 (1.1%)
Diagnoses with fewer than three patients admitted in this cohort
are not given in this table.
*Five patients had no clear aetiology of weaning failure but had
confirmed isolated postcritical care neuromyopathy without
coexisting neurological disease.
COPD, chronic obstructive pulmonary disease; ENT, ear nose and
throat.
Figure 1 Clinical outcome of patients admitted to a
specialist weaning and rehabilitation centre. NIV, non-invasive
ventilation.
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there was substantial variation between patients. Of the
168 patients who were weaned from invasive ventilation,
51 patients (29.6%) had a time-to-wean greater than
30 days.
Length-of-stay
The median length-of-stay was 31 days (IQR 16–50 days;
range 1–364 days) with no difference observed between
the diagnostic groups (p=0.242). Of the patients who
were weaned from invasive mechanical ventilation, 51
patients (29.6%) were an inpatient in the weaning and
rehabilitation centre for more than 60 days and 24
patients (14.0%) were an inpatient more than 100 days.
The time-to-wean and length-of-stay by primary diagnos-
tic group are shown in table 5.
Discharge from the weaning, rehabilitation and home
mechanical ventilation centre
The major proportion of patients discharged alive from
the specialist centre returned to the referring hospital
for further rehabilitation (n=126, 48.1%) with 78
patients (30.0%) discharged directly to home and 20
(7.7%) discharged directly to a nursing home or long-
term residential care facility. Discharge outcome data for
the cohort are shown in ﬁgure 2.
Postdischarge mortality
Of the 224 patients discharged alive, 6-month survival
status was available for 223 (99.6%) and 12-month
survival status for 215 (96.0%). Cumulative survival at
6 months was 71.7% (n=160) and at 12 months was
61.8% (n=133; ﬁgure 3). There was no difference in
mortality between the primary diagnostic groups
during the 12 months postdischarge (log rank p=0.202;
ﬁgure 4). Survival at 12 months was 70.5% (n=61) in the
neuromuscular-chest wall disease group, 69.2% (n=9) in
the ORRF group, 62.7% (n=22) in the COPD group,
56.8% (n=19) in the other diagnostic group and 53.2%
(n=23) in the postsurgical group.
DISCUSSION
In the present study, the majority of patients with
weaning failure admitted had neuromuscular and chest
wall disease as the primary diagnostic group. Weaning
success was observed in 65% of the cohort with weaning
failure and death observed in 21% and 15%, respect-
ively. There was no difference in weaning success across
the different diagnostic groups with a median
time-to-wean following admission to the specialist centre
of 19 days. Eighty-ﬁve per cent of patients survived to
hospital discharge with 62% of those discharged alive
surviving for 1 year following discharge from the
weaning and rehabilitation centre.
This is the largest observational cohort study reporting
the clinical outcome of complex patients transferred to
a specialist weaning, rehabilitation and home mechan-
ical ventilation centre. These data are timely, and indeed
Table 2 Weaning outcome by primary diagnostic group
n (%)
All patients
n=262 (%)
NMD-CWD
n=104 (%)
COPD
n=51 (%)
Postsurgical
n=55 (%)
ORRF
n=14 (%)
Other
n=38 (%)
Self-ventilating 100 (38.2) 29 (27.9) 24 (47.1) 27 (49.1) 6 (42.9) 14 (36.8)
Nocturnal NIV 63 (24.0) 35 (33.7) 9 (17.6) 8 (14.5) 6 (42.9) 5 (13.2)
Nocturnal NIV and daytime use 5 (1.9) 1 (1.0) 0 (0.0) 2 (3.6) 1 (7.1) 1 (2.6)
Long-term tracheostomy 56 (21.4) 32 (30.8) 5 (9.8) 8 (14.5) 0 (0.0) 11 (28.9)
Death 38 (14.5) 7 (6.7) 13 (25.5) 10 (18.2) 1 (7.1) 7 (18.4)
Total weaned 168 (64.1) 65 (62.5) 33 (64.7) 37 (67.3) 13 (92.9) 20 (52.6)
COPD, chronic obstructive pulmonary disease; CWD, chest wall disease; NIV, non-invasive ventilation; NMD, neuromuscular disease;
ORRF, obesity-related respiratory failure.
Table 3 Weaning success
Factor
RR for
weaning
success 95% CI p Value
Male gender 0.89 0.75 to 1.07 0.212
Outside hospital
referral
0.97 0.80 to 1.19 0.808
NMD/CWD 0.96 0.79 to 1.16 0.659
COPD 1.01 0.81 to 1.27 0.922
Postsurgical 1.06 0.86 to 1.31 0.571
ORRF 1.48 1.25 to 1.77 <0.001
COPD, chronic obstructive pulmonary disease; CWD, chest wall
disease; NMD, neuromuscular disease; ORRF, obesity-related
respiratory failure; RR, relative risk.
Table 4 Mortality within the weaning and rehabilitation
centre
Factor
RR for
death 95% CI p Value
Male gender 1.14 0.62 to 2.11 0.661
Outside hospital referral 0.73 0.39 to 1.35 0.311
NMD-CWD 0.34 0.16 to 0.75 0.007
COPD 2.15 1.19 to 3.91 0.012
Postsurgical 1.34 0.70 to 2.60 0.378
OSA-OHS 0.48 0.07 to 3.24 0.450
COPD, chronic obstructive pulmonary disease; CWD, chest wall
disease; NMD, neuromuscular disease; OHS, obesity
hypoventilation syndrome; OSA, obstructive sleep apnoea; RR,
relative risk.
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important, with the imminent implementation of the
NHSE specialist respiratory commissioning speciﬁcation
detailing complex home ventilation.17 A requirement of
this speciﬁcation will be for specialist centres to report a
clinical outcome set, including referral pattern, weaning
success, time-to-wean, weaning failure and weaning
centre mortality, which can then be benchmarked both
nationally and internationally.
Limitations of the study
Although the 1 year follow-up data were wholly accept-
able with only nine patients lost to follow-up at
12 months, the data from the referring hospitals were
incomplete, and therefore the study was unable to
comment on the total time of invasive ventilation as the
time of receiving invasive ventilation in the ICU prior to
arriving at the weaning and rehabilitation centre was not
complete and reliable. However, this can be balanced by
the admission criteria to the centre which includes inva-
sive ventilation for greater than 28 days, and so we are
conﬁdent that the patients all had weaning failure, by
deﬁnition,1 17 prior to admission. In addition, the
present study was unable to comment on the number,
and proportion, of patients referred to the centre but
who were not admitted. As expected, patients were not
admitted if they were deemed unweanable, died awaiting
transfer or were weaned locally in the referring ICU.
This may have resulted in a selection bias which would
be expected to enhance weaning outcome. These
important clinical data will need to be included in the
NHSE core outcome set for patients with weaning
failure.
Clinical outcome set for weaning
The clinical outcomes of weaning success, time-to-wean
and weaning centre mortality have improved compared
with the data we published in our smaller 3-year cohort
study.13 Interestingly, the proportion of the primary diag-
nostic groups have not changed since the previous
report, with neuromuscular and chest wall disease still
predominating. This reﬂects the historical background
of the centre for the management of patients with previ-
ous poliomyelitis syndrome and postpolio syndrome19 20
and, recently, for patients with inherited muscle disor-
ders, such as Duchenne muscular dystrophy.21 22 In the
current study, patients with neuromuscular and chest
wall disease had the lowest weaning centre mortality,
despite a comparable rate of successful weaning with the
other groups, and thus had the highest incidence of dis-
charge requiring long-term tracheostomy ventilation. A
patient with COPD had the highest weaning centre mor-
tality rate. This represents a change from the earlier
reported cohort, which found that postsurgical patients
were more likely to die during the weaning process.13
While patients with ORRF formed a small part of this
cohort, this study has conﬁrmed previous data23 24 that
the obese group are likely to successfully wean from
invasive ventilation and indeed have a 12-month survival
similar to the other groups. Notably, the time-to-wean
and length-of-stay data demonstrated large variation,
which reﬂects the challenges of managing patients with
weaning failure.
Discharge destination
The current study observed that a smaller proportion of
patients were discharged to home following successful
weaning, compared with the previous data,13 with more
patients discharged back to the referring hospital. This
is an interesting observation and reﬂects the increasing
challenges of the multidisciplinary team at specialist ter-
tiary centres liaising with multiple clinical commission-
ing group continuing healthcare teams and social
Table 5 Time-to-wean and length-of-stay in the weaning and rehabilitation centre of patients weaned from invasive
mechanical ventilation
(n)
Time-to-wean (days) Length-of-stay (days)
Median (IQR) Range Median (IQR) Range
All patients (n=168) 19 (9–33) 0–121 8 (5–13) 1–364
NMD-CWD (n=65) 20.5 (10–36) 1–112 9 (5–17) 1–57
COPD (n=33) 16 (10–28) 1–79 5 (4–10) 1–22
Postsurgical (n=37) 24.5 (7.75–37.25) 0–51 13 (4–16.75) 2–89
ORRF (n=13) 14 (9.5–34–5) 1–108 8 (5.5–13.5) 1–364
Other (n=20) 19.5 (9–31.5) 1–121 7 (4.25–13.75) 1–145
COPD, chronic obstructive pulmonary disease; CWD, chest wall disease; NMD, neuromuscular disease; ORRF, obesity-related respiratory
failure.
Figure 2 Discharge destination of patients admitted to a
specialist weaning and rehabilitation centre.
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services teams when the patient is from a distant geo-
graphical location. The effect of this is that patients
remain in the specialist centre for an extended
length-of-stay, a median of 31 days in the current study
when the time-to-wean was 19 days, which limits the
admission of further patients for assessment and review.
Indeed, the adverse effect of delayed discharge from the
weaning and rehabilitation centre has resulted in a
reduced capacity with repatriation as an expeditious
alternative to complex community discharge planning.
Figure 3 Twelve-month Kaplan-Meier survival curve for all patients discharged alive; n=223. | = censored observation (n=9).
Figure 4 Twelve-month Kaplan-Meier survival curve separated by diagnostic group, n=223, | = censored observation (n=9).
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Survival and follow-up postdischarge from the weaning
and rehabilitation centre
Although discharge mortality was low at 15%, mortality
during the ﬁrst 6 months postdischarge was twice that of
the second 6-month period postdischarge, albeit there
was no difference between the primary diagnostic
groups. This is important to acknowledge and highlight
that there are speciﬁc patients that are at a high risk of
death postdischarge. However, even in post hoc analysis
when we considered the patients in expected clinical
prognostic groups, rather than the diagnostic groups, we
could not identify a subgroup of patients at highest risk.
Indeed, in subgroup analysis, we separated the patients
as slowly progressive disease (eg, Duchenne muscular
dystrophy, postpolio), patients with conditions in recov-
ery (eg, Guillain-Barré syndrome, ICU-acquired weak-
ness25) and frail patients with rapidly progressive disease
at high risk of subsequent decline (eg, motor neuron
disease, COPD), but there was no difference in cumula-
tive survival by disease prognosis (log rank p=0.057).
Clinicians will need to follow all patients postdischarge
and determine the individual trajectory of recovery or
decline, with a focus on the ﬁrst 6 months following dis-
charge. More observational data detailing the character-
istics of the patients who recover and those who decline
are required to stratify the patients postdischarge and to
develop the optimum clinical management strategy. This
lack of stratiﬁcation may have inﬂuenced, in part, the
lack of evidence currently to support the development
of post-ICU clinics.26 27
Benchmarking
Developing a clinical outcome set for weaning and
rehabilitation centres is essential. However, just as com-
parison of ICU mortality outcomes requires deﬁning the
standardised mortality ratio to ensure the comparative
analysis is worthwhile, we must develop such an
approach for the weaning and rehabilitation centres to
accommodate the patient case mix. Although weaning
centre survival and weaning success and 12-month post-
discharge survival will be key outcome metrics, we need
to consider these in the context of the primary diagnos-
tic groups, subgroups of primary diagnostic groups and
other factors, such as age and frailty, to identify those
patients which are at high risk of clinical deterioration
within 6 months of discharge. This will allow national
and international benchmarking of such centres
and explain, in part, the wide differences reported of
both weaning success and 1-year mortality, which
currently range from 56% to 95% and 8% to 78%,
respectively, from both specialist and non-specialist
centres.4–6 8 13 15 16
Specialist weaning, rehabilitation and home ventilation
centres in the UK
There are currently few weaning, rehabilitation and
home ventilation centres in the UK, despite a report
from the UK Department of Health recommending an
expansion of such specialist services with estimated cost
savings in the region of 50% per patient per day com-
pared with managing a patient in an ICU.28 The North
of England study determined that patients with weaning
failure occupied 1000 ICU bed days per year, which can
be extrapolated to 12 500 ICU bed days annually across
the UK.29 These data have been supported by recent UK
data suggesting a reduction in ICU bed occupancy by
up to 10% with the establishment of specialist weaning
and rehabilitation centres.30 In addition, acute hospital
trusts wholly beneﬁt by the transfer of patients with
weaning failure to specialist centres as the increased crit-
ical care bed capacity can be used to maintain the high-
risk elective surgical activity for the local patients, which
will generate income for the hospital.31 Of the 3991
adult critical care beds across England,32 only a small
proportion of patients will experience weaning failure,
and indeed these patients are spread across the 240
ICUs across England. It is highly unlikely that there will
be a randomised controlled trial comparing the
outcome of specialist weaning and rehabilitation
centres, long-term acute care facilities and ICUs, and
therefore strategies to accommodate bed capacity,
case-mix and relevant clinical outcomes must be devel-
oped as part of the speciﬁcation of the NHSE complex
home ventilation programme. Indeed, these specialist
units offer bespoke weaning and rehabilitation for a
small number of patients where protocolisation, a
common feature of ICU management, is disregarded in
favour of a personalised care plan for these patients with
complex weaning failure.18
CONCLUSION
The current data demonstrate that, in our centre,
two-thirds of patients with weaning failure can be suc-
cessfully weaned with over three-quarters of patients sur-
viving to hospital discharge. In accordance with NHSE
specialist respiratory commissioning speciﬁcation for
complex home ventilation, weaning, rehabilitation and
home mechanical ventilation centres must collect a
minimum data set that represents a core clinical
outcome set, including weaning success, time-to-wean,
weaning centre mortality and 12-month mortality.
Twelve-month survival did not vary across the primary
diagnosis but further characterisation of these patients
postdischarge is required. In future, specialist centres
will need to report these data as part of both national
and international benchmarking exercises.
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